Allegro MicroSystems is in a powerful sustained uptrend, with the stock price up 55.3% over the past year. The current price of $55.485 sits at 77.3% of its 52-week range ($22.41 low to $71.77 high), indicating strong momentum but still below the peak, suggesting room for further upside without being overextended. The stock has more than doubled from its 52-week low, reflecting a robust recovery from earlier weakness. Short-term momentum is accelerating sharply, with a 1-month price change of +10.2% and a 3-month change of +70.2%, far outpacing the S&P 500's 1-month decline of -1.25% and 3-month gain of 13.6%. This divergence signals that Allegro is experiencing a powerful catalyst-driven rally, likely tied to improving fundamentals and sector rotation into semiconductors. The 1-year trend is strongly bullish, and the recent acceleration confirms the uptrend is intact. The 52-week high of $71.77 represents key resistance; a breakout above that level would signal a continuation of the uptrend and could open the door to further gains. The 52-week low of $22.41 serves as major support, though the stock is far above that level. Beta is 1.897, meaning the stock is nearly 90% more volatile than the S&P 500, which amplifies both upside and downside moves. This high beta underscores the need for careful position sizing, especially given the recent rapid ascent.

Revenue is on a strong growth trajectory, with the most recent quarter (Q3 FY2026, ended Dec 26, 2025) reporting $229.2 million, up 28.9% year-over-year. This marks a significant acceleration from the prior year's quarters, where revenue was $177.9 million (Q3 FY2025) and $192.8 million (Q4 FY2025). The growth is driven by both Magnetic Sensors ($137.8M) and Power ICs ($91.4M) segments, indicating broad-based demand. The multi-quarter trend shows a clear inflection from a trough in early 2025, with sequential revenue growth of 7.0% from Q2 FY2026 ($214.3M), reinforcing the recovery narrative. The company has returned to profitability, with net income of $8.3 million in Q3 FY2026, compared to losses in the prior four quarters. Gross margin improved to 46.7% from 41.4% a year ago, reflecting better product mix and operating leverage. Operating margin turned positive at 4.2%, a sharp improvement from -6.8% in Q4 FY2025. While still below industry peers, the margin trajectory is encouraging and suggests the company is benefiting from cost controls and higher volumes. The balance sheet is healthy, with a current ratio of 3.45 and a low debt-to-equity ratio of 0.30, indicating ample liquidity and conservative leverage. Free cash flow was $41.3 million in Q3 FY2026, and trailing twelve-month FCF stands at $121.2 million, providing internal funding for growth. ROE is slightly negative at -1.6% on a trailing basis, but the recent profitable quarter suggests improvement ahead. The company does not pay a dividend, instead reinvesting cash into the business.